Peter J Fuller Selected Research

Steroids

8/2012	Protein arginine methyltransferase 6-dependent gene expression and splicing: association with breast cancer outcomes.
10/2007	Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
3/2007	3rd PacRim Breast and Prostate Cancer Meeting. 31 October-4 November 2006, Fraser Island, Queensland, Australia.
7/2006	Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone/salt rats.
7/2005	Seladin-1/DHCR24 expression in normal ovary, ovarian epithelial and granulosa tumours.
2/2003	International congress on hormonal steroids and hormones in cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter J Fuller Research Topics

Disease

22	Hypertension (High Blood Pressure) 03/2024 - 01/2004
19	Hyperaldosteronism (Conn Syndrome) 03/2024 - 01/2018
18	Neoplasms (Cancer) 08/2015 - 01/2002
14	Granulosa Cell Tumor 01/2019 - 03/2002
10	Fibrosis (Cirrhosis) 01/2023 - 12/2005
10	Inflammation (Inflammations) 01/2023 - 07/2006
8	Breast Neoplasms (Breast Cancer) 11/2020 - 03/2007
7	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 10/2004
6	Heart Failure 09/2021 - 12/2008
4	Weight Gain 03/2010 - 10/2004
3	Hypokalemia 03/2024 - 10/2019
3	Cardiomegaly (Heart Hypertrophy) 09/2021 - 10/2007
3	Short Bowel Syndrome 11/2014 - 01/2008
3	Serous Cystadenocarcinoma 07/2013 - 03/2002
2	Hypercalciuria 09/2017 - 04/2016
2	Urolithiasis 09/2017 - 04/2016
2	beta-Thalassemia (Cooley's Anemia) 04/2016 - 01/2012
2	Adenoma (Adenomas) 03/2016 - 11/2013
2	Thalassemia 01/2016 - 11/2014
2	Iron Overload 01/2016 - 01/2012
2	Goiter 08/2015 - 06/2014
2	Carcinogenesis 07/2014 - 08/2012
2	Carcinoma (Carcinomatosis) 06/2014 - 02/2012
2	Ovarian Neoplasms (Ovarian Cancer) 08/2012 - 10/2010
2	Granulosa cell tumor of the ovary 12/2010 - 04/2010
2	Leiomyoma (Uterine Fibroids) 09/2005 - 08/2002
1	Septic Shock (Toxic Shock Syndrome) 11/2023
1	Graves Disease (Basedow Disease) 05/2023
1	Thyrotoxicosis 05/2023
1	Hypothyroidism 05/2023
1	Disease Progression 05/2023
1	Hyponatremia 01/2023
1	Glucocorticoid Receptor Deficiency 01/2022
1	Stroke (Strokes) 10/2021
1	Chronic Renal Insufficiency 01/2021

Drug/Important Bio-Agent (IBA)

17	AldosteroneIBA 10/2023 - 12/2005
15	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2024 - 10/2004
11	SaltsIBA 01/2020 - 01/2004
10	Messenger RNA (mRNA)IBA 12/2016 - 01/2002
9	ReninIBA 01/2024 - 01/2020
7	PotassiumIBA 08/2023 - 10/2019
7	Hormones (Hormone)IBA 03/2016 - 01/2002
7	Estrogens (Estrogen)FDA Link 09/2014 - 08/2002
6	Antihypertensive Agents (Antihypertensives)IBA 12/2022 - 10/2019
6	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2020 - 06/2011
6	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2012
6	Estrogen ReceptorsIBA 07/2014 - 08/2002
6	SteroidsIBA 08/2012 - 02/2003
5	MineralocorticoidsIBA 11/2020 - 12/2006
5	RNA (Ribonucleic Acid)IBA 12/2016 - 06/2014
5	Inhibins (Inhibin)IBA 12/2013 - 01/2002
5	Aromatase (CYP19)IBA 11/2013 - 01/2002
4	GlucocorticoidsIBA 11/2023 - 12/2006
4	SodiumIBA 01/2023 - 01/2004
4	LigandsIBA 11/2020 - 04/2009
4	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2017 - 07/2006
3	Mineralocorticoid Receptor AntagonistsIBA 03/2024 - 01/2022
3	Captopril (Capoten)FDA LinkGeneric 01/2024 - 01/2020
3	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2023 - 03/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2002
3	IronIBA 04/2016 - 01/2012
3	Phosphotransferases (Kinase)IBA 01/2016 - 11/2008
3	betaglycan (TGFBR3)IBA 03/2013 - 03/2002
3	Estrogen Receptor betaIBA 04/2010 - 08/2002
3	Eplerenone (Inspra)FDA LinkGeneric 10/2007 - 10/2004
3	Estrogen Receptor alphaIBA 03/2007 - 08/2002
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 12/2006
2	CalciumIBA 09/2021 - 09/2017
2	RetinoidsIBA 11/2020 - 07/2014
2	Anticonvulsants (Antiepileptic Drugs)IBA 10/2019 - 10/2017
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2019 - 08/2015
2	Deferasirox FDA Link 04/2016 - 01/2012
2	Chelating AgentsIBA 04/2016 - 01/2016
2	Bile Acids and Salts (Bile Acids)IBA 11/2014 - 03/2010
2	Tumor Biomarkers (Tumor Markers)IBA 02/2012 - 01/2002
2	CorticosteroneIBA 06/2010 - 05/2009
2	NF-kappa B (NF-kB)IBA 04/2010 - 04/2009
2	Follicle Stimulating Hormone (Follitropin)FDA Link 04/2009 - 11/2008
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 05/2008 - 11/2004
2	Sucrase (Sucrose alpha-D-Glucohydrolase)IBA 01/2008 - 10/2004
2	alpha-Glucosidases (Acid Maltase)IBA 01/2008 - 10/2004
2	DisaccharidasesIBA 01/2008 - 10/2004
2	SolutionsIBA 10/2007 - 07/2006
2	Saline SolutionIBA 10/2007 - 07/2006
1	FludrocortisoneIBA 11/2023
1	GoldIBA 10/2023
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 05/2023
1	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2023
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 05/2023
1	CarbimazoleIBA 05/2023
1	thyrotropin-binding inhibitory immunoglobulinIBA 05/2023
1	Immunoglobulins (Immunoglobulin)IBA 05/2023
1	AntibodiesIBA 05/2023
1	Thyroid-Stimulating ImmunoglobulinsIBA 05/2023
1	Proanthocyanidins (Procyanidins)IBA 09/2021
1	finerenoneIBA 01/2021
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021

Therapy/Procedure

7	Therapeutics 01/2022 - 03/2007
5	Adrenalectomy 12/2022 - 10/2019
1	Contraception (Birth Control) 01/2023